Articles written by: Nicholas Wake

Reviewing Aquestive Therapeutics Inc. (AQST)’s and Mirati Therapeutics Inc. (NASDAQ:MRTX)’s results

Both Aquestive Therapeutics Inc. (NASDAQ:AQST) and Mirati Therapeutics Inc. (NASDAQ:MRTX) are Biotechnology companies, competing one another. We will contrast their risk, analyst recommendations, profitability, dividends, institutional ownership, earnings and valuation. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Aquestive Therapeutics Inc. 67.43M 2.30 61.38M […]

$-0.13 EPS Expected for Alcoa (AA); Vulcan Value Partners Decreased Its Parker Hannifin (PH) Holding

$-0.13 EPS Expected for Alcoa (AA); Vulcan Value Partners Decreased Its Parker Hannifin (PH) Holding

Vulcan Value Partners Llc decreased Parker Hannifin Corp (PH) stake by 9.15% reported in 2018Q4 SEC filing. Vulcan Value Partners Llc sold 288,561 shares as Parker Hannifin Corp (PH)’s stock rose 3.34%. The Vulcan Value Partners Llc holds 2.86M shares with $427.26 million value, down from 3.15M last quarter. Parker […]

Sesen Bio Inc. (SESN) and TCR2 Therapeutics Inc. (NASDAQ:TCRR) Contrasting side by side

As Biotechnology companies, Sesen Bio Inc. (NASDAQ:SESN) and TCR2 Therapeutics Inc. (NASDAQ:TCRR) are our subject to contrast. And more specifically their profitability, analyst recommendations, risk, dividends, institutional ownership, earnings and valuation. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Sesen Bio Inc. N/A 0.00 […]

Pioneer Trust Bank N A Has Increased Its Chevron Com (CVX) Stake; Stepan Company (SCL) SI Increased By 11.61%

Pioneer Trust Bank N A Has Increased Its Chevron Com (CVX) Stake; Stepan Company (SCL) SI Increased By 11.61%

Stepan Company (NYSE:SCL) had an increase of 11.61% in short interest. SCL’s SI was 257,700 shares in March as released by FINRA. Its up 11.61% from 230,900 shares previously. With 70,100 avg volume, 4 days are for Stepan Company (NYSE:SCL)’s short sellers to cover SCL’s short positions. The SI to […]

Reviewing Jupai Holdings Limited (JP)’s and RiverNorth/DoubleLine Strategic Opportunity Fund Inc. (NYSE:OPP)’s results

As Asset Management companies, Jupai Holdings Limited (NYSE:JP) and RiverNorth/DoubleLine Strategic Opportunity Fund Inc. (NYSE:OPP) are our subject to contrast. And more specifically their profitability, institutional ownership, analyst recommendations, risk, dividends, earnings and valuation. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Jupai Holdings […]